These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22581754)

  • 1. Subject movement during multislice interleaved MR acquisitions: prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis.
    Gedamu EL; Gedamu A
    J Magn Reson Imaging; 2012 Aug; 36(2):332-43. PubMed ID: 22581754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and measurement of coverage loss in interleaved multi-acquisition brain MRIs due to motion-induced inter-slice misalignment.
    Tam RC; Riddehough A; Li DK
    Med Image Anal; 2009 Jun; 13(3):381-91. PubMed ID: 19200772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis.
    Zijdenbos AP; Forghani R; Evans AC
    IEEE Trans Med Imaging; 2002 Oct; 21(10):1280-91. PubMed ID: 12585710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating intensity normalization on MRIs of human brain with multiple sclerosis.
    Shah M; Xiao Y; Subbanna N; Francis S; Arnold DL; Collins DL; Arbel T
    Med Image Anal; 2011 Apr; 15(2):267-82. PubMed ID: 21233004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Approaches to segment multiple-sclerosis lesions on conventional brain MRI].
    Souplet JC; Lebrun C; Chanalet S; Ayache N; Malandain G
    Rev Neurol (Paris); 2009 Jan; 165(1):7-14. PubMed ID: 18808780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials.
    Moraal B; van den Elskamp IJ; Knol DL; Uitdehaag BM; Geurts JJ; Vrenken H; Pouwels PJ; van Schijndel RA; Meier DS; Guttmann CR; Barkhof F
    Ann Neurol; 2010 May; 67(5):667-75. PubMed ID: 20437564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnetic resonance imaging in multiple sclerosis].
    Tourbah A; Berry I
    Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
    Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
    Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis.
    Filippi M; Horsfield MA; Adèr HJ; Barkhof F; Bruzzi P; Evans A; Frank JA; Grossman RI; McFarland HF; Molyneux P; Paty DW; Simon J; Tofts PS; Wolinsky JS; Miller DH
    Ann Neurol; 1998 Apr; 43(4):499-506. PubMed ID: 9546332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequences.
    Filippi M; Rocca MA; Gasperini C; Sormani MP; Bastianello S; Horsfield MA; Pozzilli C; Comi G
    AJNR Am J Neuroradiol; 1999 Jan; 20(1):133-7. PubMed ID: 9974068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring brain atrophy in multiple sclerosis.
    De Stefano N; Battaglini M; Smith SM
    J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of multiple sclerosis lesion load and brain tissue volumetry using multiparameter MRI: methodology and reproducibility.
    Ding Z; Preiningerova J; Cannistraci CJ; Vollmer TL; Gore JC; Anderson AW
    Magn Reson Imaging; 2005 Apr; 23(3):445-52. PubMed ID: 15862645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance image registration in multiple sclerosis: comparison with repositioning error and observer-based variability.
    Tan IL; van Schijndel RA; van Walderveen MA; Quist M; Bos R; Pouwels PJ; Desmedt P; Adèr HJ; Barkhof F
    J Magn Reson Imaging; 2002 May; 15(5):505-10. PubMed ID: 11997890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
    Inglese M; Grossman RI; Filippi M
    J Neuroimaging; 2005; 15(4 Suppl):22S-29S. PubMed ID: 16385016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis.
    van den Elskamp IJ; Knol DL; Vrenken H; Karas G; Meijerman A; Filippi M; Kappos L; Fazekas F; Wagner K; Pohl C; Sandbrink R; Polman CH; Uitdehaag BM; Barkhof F
    Mult Scler; 2010 Jun; 16(6):660-9. PubMed ID: 20350960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor evoked potential: a reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRI.
    Kalkers NF; Strijers RL; Jasperse MM; Neacsu V; Geurts JJ; Barkhof F; Polman CH; Stam CJ
    Clin Neurophysiol; 2007 Jun; 118(6):1332-40. PubMed ID: 17398151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements.
    Sampat MP; Healy BC; Meier DS; Dell'Oglio E; Liguori M; Guttmann CR
    Neuroimage; 2010 Oct; 52(4):1367-73. PubMed ID: 20362675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective and retrospective motion correction in diffusion magnetic resonance imaging of the human brain.
    Kober T; Gruetter R; Krueger G
    Neuroimage; 2012 Jan; 59(1):389-98. PubMed ID: 21763773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI texture analysis in multiple sclerosis: toward a clinical analysis protocol.
    Harrison LC; Raunio M; Holli KK; Luukkaala T; Savio S; Elovaara I; Soimakallio S; Eskola HJ; Dastidar P
    Acad Radiol; 2010 Jun; 17(6):696-707. PubMed ID: 20457414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.